Literature DB >> 7511605

The cytoplasmic domain of myelin glycoprotein P0 interacts with negatively charged phospholipid bilayers.

Y Ding1, K R Brunden.   

Abstract

The intracellular COOH-terminal domain of the glycoprotein, P0, has been proposed to be involved in the formation of the major dense line of peripheral myelin. We have addressed this hypothesis by generating and subsequently isolating a peptide fragment that contains 65 of the 69 residues of the cytoplasmic region of rat P0. This peptide, termed P0(intra), bound to artificial phospholipid vesicles and caused their rapid aggregation. The peptide-induced aggregation of membrane bilayers appeared to result from ionic interactions, since P0(intra) vesicle association was decreased by 1) reducing the phosphatidylserine content of the membranes, 2) increasing the NaCl concentration of the surrounding buffer, or 3) elevating the divalent cation concentration within the buffers. Cationic disc gel electrophoresis of P0(intra) revealed at least four charge isoforms of the peptide. Treatment of sciatic nerve slices with phorbol ester prior to isolation of P0(intra) increased the amount of the more negatively charged species, suggesting that at least some of the charge heterogeneity of the peptide can be attributed to differing phosphorylation states. The ability of P0(intra) to bind to phospholipid bilayers implies that the cytoplasmic domain of P0 may be responsible for the formation and maintenance of the myelin major dense line.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin.

Authors:  Xiaoyang Luo; Deepak Sharma; Hideyo Inouye; Daniel Lee; Robin L Avila; Mario Salmona; Daniel A Kirschner
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

3.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

4.  Myelin sheaths are formed with proteins that originated in vertebrate lineages.

Authors:  Robert M Gould; Todd Oakley; Jared V Goldstone; Jason C Dugas; Scott T Brady; Alexander Gow
Journal:  Neuron Glia Biol       Date:  2008-05

Review 5.  Phosphorylation of myelin protein: recent advances.

Authors:  J Eichberg; S Iyer
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

6.  Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.

Authors:  Mehrdad Khajavi; Ken Inoue; Wojciech Wiszniewski; Tomoko Ohyama; G Jackson Snipes; James R Lupski
Journal:  Am J Hum Genet       Date:  2005-09-30       Impact factor: 11.025

7.  Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin.

Authors:  D D'Urso; P Ehrhardt; H W Müller
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

8.  Purification of P0 myelin glycoprotein by a Cu2+-immobilized metal affinity chromatography.

Authors:  J Sedzik; Y Kotake; K Uyemura
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

Review 9.  Animal models for inherited peripheral neuropathies.

Authors:  R Martini
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

Review 10.  Molecular anatomy and genetics of myelin proteins in the peripheral nervous system.

Authors:  G J Snipes; U Suter
Journal:  J Anat       Date:  1995-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.